Quadrature Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Quadrature Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.8M	Buy	+483,532	New	+$60.4M	0.73%	28
2025 Q4	–	Sell	-45,501	Closed	-$4.56M	–	1706
2025 Q3	$4.56M	Buy	+45,501	New	+$4.1M	0.05%	208
2024 Q2	–	Sell	-89,384	Closed	-$8.48M	–	1580
2024 Q1	$8.48M	Buy	+89,384	New	+$8.29M	0.15%	122

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Quadrature Capital's XBI Position: Q1 2026 in Review

Quadrature Capital opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 483,532 shares worth $61.8M. The stake represents 0.73% of the portfolio and ranks #28 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in XBI as recently as Q3 2025.

Quadrature Capital first reported a position in XBI in Q1 2024 and has held it in 3 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Quadrature Capital held 483,532 shares of State Street SPDR S&P Biotech ETF worth $61.8M as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Quadrature Capital position in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.73% of Quadrature Capital's portfolio in Q1 2026, its #28 holding.
Quadrature Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 3 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.